NCT03872544 (FTFDT3) is a clinical trial in Wound; Head, Multiple, sponsored by Dufresne, Craig, MD, PC.

Who is sponsoring NCT03872544?

NCT03872544 is sponsored by Dufresne, Craig, MD, PC.

What condition does NCT03872544 study?

NCT03872544 studies Wound; Head, Multiple, Wound; Head, Scalp, Wound; Head, Wound Infection, Wound Complication, Wound Dehiscence, Wound of Skin, Wound Open, Wounds, Penetrating, Wounds, Nonpenetrating, Wounds and Injuries, Wounds, Disturbance of Wound Healing, Facial Bones Fracture, Soft Tissue Injuries, Skull Fractures, Surgical Wound, Surgical Wound Infection, Wound Healing.

Is NCT03872544 still recruiting?

NCT03872544 is currently status unknown. Last updated 16 June 2022.

Last reviewed 2022-06-16 · How we verify

NCT03872544: FTFDT3

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds

Status unknown Last updated 16 June 2022

What this trial tests

trial in Wound; Head, Multiple in 20 participants. Status unknown.

Timeline

20 September 2023

Primary endpoint
20 September 2024

11 November 2025

Quick facts

Lead sponsor	Dufresne, Craig, MD, PC
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	20 September 2023
Primary completion	20 September 2024
Estimated completion	11 November 2025
Sites	1 location across United States

Conditions studied

Wound; Head, Multiple — all drugs for Wound; Head, Multiple →
Wound; Head, Scalp — all drugs for Wound; Head, Scalp →
Wound; Head — all drugs for Wound; Head →
Wound Infection — all drugs for Wound Infection →

Sponsor

Dufresne, Craig, MD, PC

Who can join

Eligibility, any sex, with Wound; Head, Multiple or Wound; Head, Scalp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the use of free autologous dermal fat grafting (also called free dermal fat autografting) to treat complex craniofacial wounds that have failed standard treatment and to understand how well these grafts work to repair wounds long term. Patients who have undergone free autologous dermal fat grafting to treat complex craniofacial wounds less than 1 week ago will have photographs and small biopsies taken of the area that was grafted. Patients will be followed for 2 years to monitor the area that was grafted.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Adipose-derived stromal cells for nonhealing wounds: Emerging opportunities and challenges.
Deptuła M, Brzezicka A, Skoniecka A, Zieliński J, et al · · 2021 · cited 38× · PMID 33522005 · DOI 10.1002/med.21789

Verify or expand the search:

Other Dufresne, Craig, MD, PC trials

Trials by the same sponsor.

NCT03880188 — Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03872544 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dufresne, Craig, MD, PC
Last refreshed: 16 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03872544.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing